On December 6, 2024, David Landman, Director at Inotiv Inc, purchased 100,000 shares of the company. Following this transaction, the insider now holds a total of 153,322 shares. The transaction details can be found in the SEC Filing.
Inotiv Inc (NOTV, Financial) is a contract research organization that provides nonclinical and analytical drug discovery and development services. The company supports pharmaceutical and biotechnology companies in their research and development efforts.
The insider transaction history for Inotiv Inc indicates that there have been four insider purchases over the past year, with no insider sales during the same period. This trend suggests a positive sentiment among insiders regarding the company's prospects.
On the day of the recent purchase, shares of Inotiv Inc were trading at $4.14, resulting in a market cap of $120.189 million. The stock's GF Value is estimated at $4.88, giving it a price-to-GF-Value ratio of 0.85. This indicates that the stock is fairly valued according to its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company's past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
